Portfolio of Renaissance Technologies

Renaissance Technologies was founded by Jim Simons († 2024) and makes investment decisions with mathematical models; the portfolio holds a very large number of stocks.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 13, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2020. Go to the latest filing (Q3 2026)

100.2B USDQ3 2020
Total value of stock positions
100.2B USD
Positions
3,333
Share of the ten largest
15.1%

The ten largest positions Q3 2020

  1. Zoom Video Communications In 2.5%▼ −27.7%
  2. Novo Nordisk (ADR) 1.9%▼ −2.1%
  3. Bristol Myers Squibb 1.8%▼ −29.7%
  4. Vertex Pharmaceuticals 1.4%▼ −9.9%
  5. Chipotle Mexican Grill 1.4%▼ −29.4%
  6. Verisign 1.3%▼ −10.1%
  7. Baidu (ADR) 1.3%▲ +9.1%
  8. AbbVie 1.2%▼ −29.2%
  9. Biogen 1.1%▼ −2.3%
  10. Target Corporation 1.1%▼ −13.3%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 130.1B USD).
Choose a quarter (54 filings)

All positions Q3 2020

Positions Q3 2020 per 13F filing, 50 of 3333
Symbol Weight Shares Reported value Change Held since
Zoom Video Communications In 2.5% 5,247,859 2.5B USD −27.7% reduced Q1 2020 3 quarters
NVO Novo Nordisk (ADR) 1.9% 28,121,231 2.0B USD −2.1% reduced Q2 2013 or earlier 30 quarters
BMY Bristol Myers Squibb 1.8% 30,576,427 1.8B USD −29.7% reduced Q2 2016 18 quarters
VRTX Vertex Pharmaceuticals 1.4% 5,206,932 1.4B USD −9.9% reduced Q1 2017 15 quarters
CMG Chipotle Mexican Grill 1.4% 1,139,042 1.4B USD −29.4% reduced Q4 2016 16 quarters
VRSN Verisign 1.3% 6,573,190 1.3B USD −10.1% reduced Q2 2013 or earlier 30 quarters
BIDU Baidu (ADR) 1.3% 10,545,158 1.3B USD +9.1% increased Q3 2019 5 quarters
ABBV AbbVie 1.2% 13,470,803 1.2B USD −29.2% reduced Q1 2018 11 quarters
BIIB Biogen 1.1% 3,816,961 1.1B USD −2.3% reduced Q1 2018 11 quarters
TGT Target Corporation 1.1% 6,829,197 1.1B USD −13.3% reduced Q1 2019 7 quarters
TEAM Atlassian 1.1% 5,897,814 1.1B USD −13.7% reduced Q2 2016 18 quarters
MNST Monster Beverage 1.0% 12,484,290 1.0B USD −3.3% reduced Q1 2014 27 quarters
KR Kroger 1.0% 29,128,088 987.7M USD +11.1% increased Q2 2019 6 quarters
PANW Palo Alto Networks 1.0% 3,928,604 961.5M USD −21.3% reduced Q2 2015 22 quarters
PDD PDD Holdings 0.9% 11,675,773 865.8M USD +4.7% increased Q2 2019 6 quarters
Franco Nev Corp 0.7% 5,354,183 747.3M USD −5.6% reduced Q1 2014 27 quarters
Glaxosmithkline PLC 0.7% 18,329,654 689.9M USD −10.8% reduced Q2 2013 or earlier 30 quarters
Horizon Therapeutics Pub L 0.7% 8,780,875 682.1M USD −14.9% reduced Q2 2019 6 quarters
EBAY eBay Inc. 0.7% 12,850,934 669.5M USD −3.2% reduced Q1 2019 7 quarters
HUM Humana 0.7% 1,598,142 661.5M USD −31.3% reduced Q2 2015 22 quarters
Abiomed Inc 0.6% 2,257,123 625.4M USD +0.3% increased Q1 2015 23 quarters
Molina Healthcare Inc 0.6% 3,355,159 614.1M USD −8.7% reduced Q2 2013 or earlier 30 quarters
Barrick Gold Corp 0.6% 21,467,447 603.4M USD −19.9% reduced Q2 2014 26 quarters
REGN Regeneron Pharmaceuticals 0.6% 1,072,362 600.3M USD +20.5% increased Q3 2017 13 quarters
DPZ Domino's 0.6% 1,385,425 589.2M USD −10.0% reduced Q2 2013 or earlier 30 quarters
Novartis AG 0.6% 6,681,808 581.1M USD −19.4% reduced Q3 2013 29 quarters
HSY Hershey Company (The) 0.6% 3,976,338 570.0M USD −20.9% reduced Q2 2013 or earlier 30 quarters
INCY Incyte 0.6% 6,205,350 556.9M USD −1.1% reduced Q4 2017 12 quarters
Exelixis Inc 0.6% 22,665,610 554.2M USD −1.5% reduced Q3 2016 17 quarters
FTNT Fortinet 0.5% 4,642,687 547.0M USD −22.3% reduced Q3 2015 21 quarters
Alexion Pharmaceuticals Inc 0.5% 4,757,243 544.4M USD +6.2% increased Q3 2018 9 quarters
NTES NetEase 0.5% 1,180,138 536.6M USD −5.0% reduced Q2 2019 6 quarters
Cable One Inc 0.5% 284,400 536.2M USD −7.0% reduced Q4 2015 20 quarters
Vodafone Group PLC New 0.5% 39,492,200 530.0M USD +3.3% increased Q3 2015 21 quarters
Herbalife Nutrition Ltd 0.5% 10,980,278 512.2M USD −0.2% reduced Q3 2015 21 quarters
NEM Newmont 0.5% 8,013,232 508.4M USD −37.7% reduced Q3 2017 13 quarters
CLX Clorox 0.5% 2,362,513 496.5M USD +24.5% increased Q2 2013 or earlier 30 quarters
GILD Gilead Sciences 0.5% 7,651,879 483.5M USD −14.0% reduced Q4 2014 24 quarters
Icon PLC 0.5% 2,504,119 478.5M USD −2.5% reduced Q2 2013 or earlier 30 quarters
Jazz Pharmaceuticals PLC 0.5% 3,334,950 475.5M USD −4.1% reduced Q2 2015 22 quarters
ALGN Align Technology 0.5% 1,444,548 472.9M USD −34.7% reduced Q2 2013 or earlier 30 quarters
Marketaxess HLDGS Inc 0.5% 966,664 465.5M USD −6.7% reduced Q4 2016 16 quarters
Etsy Inc 0.4% 3,687,861 448.6M USD −17.3% reduced Q4 2015 20 quarters
PG Procter & Gamble 0.4% 3,064,529 425.9M USD +148.2% increased Q1 2020 3 quarters
Boston Beer Inc 0.4% 462,117 408.2M USD −4.5% reduced Q3 2018 9 quarters
GIS General Mills 0.4% 6,518,668 402.1M USD +20.1% increased Q4 2018 8 quarters
Kinross Gold Corp 0.4% 44,660,331 393.9M USD −15.5% reduced Q2 2013 or earlier 30 quarters
FFIV F5, Inc. 0.4% 3,172,974 389.5M USD +1.2% increased Q3 2014 25 quarters
Dropbox Inc 0.4% 20,199,888 389.1M USD −9.1% reduced Q1 2019 7 quarters
United Therapeutics Corp Del 0.4% 3,709,018 374.6M USD −0.5% reduced Q2 2013 or earlier 30 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 largest of 3,333 positions.

Breakdown by sector

  • Health Care 10.3%
  • Consumer Staples 7.1%
  • Technology 6.9%
  • Consumer Discretionary 3.8%
  • Communication Services 2.2%
  • Industrials 1.9%
  • Financials 1.6%
  • Utilities 1.1%
  • Real Estate 0.9%
  • Materials 0.9%
  • Energy 0.4%
  • not in our coverage 62.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close